Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis.
COVID-19
SARS-CoV-2
decentralized
depression severity
heart rate
major depressive disorder
multiple sclerosis
physical activity
social activity
stress
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Dec 2022
01 Dec 2022
Historique:
received:
05
10
2022
revised:
22
11
2022
accepted:
28
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
12
12
2022
Statut:
epublish
Résumé
Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS). Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
Sections du résumé
BACKGROUND
BACKGROUND
Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS).
METHODS
METHODS
Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender.
RESULTS
RESULTS
Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods.
CONCLUSIONS
CONCLUSIONS
Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
Identifiants
pubmed: 36498739
pii: jcm11237163
doi: 10.3390/jcm11237163
pmc: PMC9738639
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Alzheimer's Society
ID : 171
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17214
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K015516/1
Pays : United Kingdom
Organisme : the Innovative Medicines Initiative 2 Joint Undertaking
ID : 115902
Références
JMIR Mhealth Uhealth. 2017 Mar 16;5(3):e34
pubmed: 28302596
Mult Scler Relat Disord. 2018 Aug;24:64-68
pubmed: 29957350
J Affect Disord. 2018 Aug 1;235:456-466
pubmed: 29679898
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Public Econ. 2021 Jan;193:104346
pubmed: 33281237
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Sport Sci Health. 2022;18(1):155-163
pubmed: 34108999
JMIR Mhealth Uhealth. 2019 Mar 11;7(3):e10828
pubmed: 30855232
JMIR Mhealth Uhealth. 2019 Jan 30;7(1):e11325
pubmed: 30698535
Psychiatry Res. 2021 Feb;296:113648
pubmed: 33348199
Physiother Can. 2019 Summer;71(3):197-206
pubmed: 31719715
Lancet Digit Health. 2020 Feb;2(2):e85-e93
pubmed: 33334565
Physiol Meas. 2010 Sep;31(9):1271-90
pubmed: 20702919
Neurol Sci. 2020 Jul;41(7):1647-1650
pubmed: 32617741
J Occup Med Toxicol. 2020 Aug 12;15:25
pubmed: 32817753
Mult Scler Relat Disord. 2019 Jul;32:123-132
pubmed: 31125754
J Neurol Sci. 2017 Jan 15;372:331-341
pubmed: 28017241
J Affect Disord. 2021 Sep 1;292:464-470
pubmed: 34146897
Rehabil Nurs. 2019 Jan/Feb;44(1):52-59
pubmed: 30601432
IEEE Trans Biomed Eng. 2021 Apr;68(4):1273-1281
pubmed: 32960759
Int J MS Care. 2016 Mar-Apr;18(2):71-7
pubmed: 27134580
J Clin Monit Comput. 2008 Feb;22(1):23-9
pubmed: 17987395
Int J Environ Res Public Health. 2021 Aug 31;18(17):
pubmed: 34501758
Depress Anxiety. 2019 Oct;36(10):975-986
pubmed: 31348850
BMJ. 2004 Mar 27;328(7442):731
pubmed: 15033880
Mult Scler. 2015 Jul;21(8):1064-71
pubmed: 25583846
Am J Psychiatry. 2018 Jul 1;175(7):631-648
pubmed: 29690792
Sci Rep. 2016 Jun 10;6:27593
pubmed: 27283116
Neurosci Biobehav Rev. 2012 Feb;36(2):747-56
pubmed: 22178086
Nat Rev Neurol. 2014 Sep;10(9):507-17
pubmed: 25112509
Handb Clin Neurol. 2018;159:237-250
pubmed: 30482317
Depress Anxiety. 2021 Oct;38(10):1026-1033
pubmed: 34370885
J Addict Med. 2021 Sep-Oct 01;15(5):383-389
pubmed: 33156181
J Clin Med. 2019 Dec 18;9(1):
pubmed: 31861312
BMC Psychiatry. 2019 Feb 18;19(1):72
pubmed: 30777041
Fisc Stud. 2020 Sep;41(3):653-683
pubmed: 33362314
Sci Rep. 2021 Sep 28;11(1):19241
pubmed: 34584107
Biol Psychiatry. 2010 Jun 1;67(11):1067-74
pubmed: 20138254
Mult Scler Relat Disord. 2020 Oct;45:102407
pubmed: 32702641
JACC Basic Transl Sci. 2021 Apr 27;6(4):384-387
pubmed: 33997523
Aust N Z J Psychiatry. 2002 Apr;36(2):173-82
pubmed: 11982537
Front Public Health. 2017 Sep 28;5:258
pubmed: 29034226
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
JMIR Mhealth Uhealth. 2020 Sep 8;8(9):e18694
pubmed: 32897239
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e11734
pubmed: 31373275
J Med Internet Res. 2018 Jul 12;20(7):e10480
pubmed: 30001997
Drug Alcohol Depend. 2021 Feb 1;219:108461
pubmed: 33454159
EClinicalMedicine. 2021 Jun;36:100916
pubmed: 34131640
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788
pubmed: 32526627
Clin Psychol Rev. 2016 Jun;46:136-50
pubmed: 27185312
Eur Psychiatry. 2020 May 20;63(1):e45
pubmed: 32431255
J Affect Disord. 2022 Jan 1;296:567-576
pubmed: 34600966
J Affect Disord. 2018 Mar 15;229:231-238
pubmed: 29329054
BMC Psychiatry. 2022 Feb 21;22(1):136
pubmed: 35189842
PLoS One. 2020 Feb 5;15(2):e0227709
pubmed: 32023264
Glob Heart. 2021 Jul 13;16(1):47
pubmed: 34381669
Pattern Recognit. 2022 Mar;123:108403
pubmed: 34720200
Ann Epidemiol. 2012 Jun;22(6):388-96
pubmed: 22625996
J Clin Med. 2020 Jan 24;9(2):
pubmed: 31991711
Int J Biosens Bioelectron. 2018;4(4):195-202
pubmed: 30906922
J Affect Disord. 2012 Feb;136(3):505-13
pubmed: 22119082
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13444-13449
pubmed: 27821732
Lancet Public Health. 2022 May;7(5):e417-e426
pubmed: 35461592
J Affect Disord. 2017 Mar 01;210:139-150
pubmed: 28033521
JMIR Mhealth Uhealth. 2020 May 7;8(5):e16043
pubmed: 32379055
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Psychol Med. 2019 Sep;49(12):1948-1957
pubmed: 31239003
Psychiatry Investig. 2018 Mar;15(3):235-245
pubmed: 29486547
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Neurosci. 2009;119(3):315-35
pubmed: 19116839
Front Psychiatry. 2019 Jan 10;9:762
pubmed: 30687141
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Health Serv Res Manag Epidemiol. 2022 Jul 6;9:23333928221111864
pubmed: 35832488
Front Psychol. 2021 Jul 27;12:689396
pubmed: 34385959
Int Psychogeriatr. 2020 Oct;32(10):1217-1220
pubmed: 32450943
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
Public Health. 2020 Sep;186:31-34
pubmed: 32768621
BMC Psychiatry. 2021 Sep 6;21(1):435
pubmed: 34488697
Annu Rev Clin Psychol. 2005;1:607-28
pubmed: 17716101
J Med Internet Res. 2020 Sep 25;22(9):e19992
pubmed: 32877352